Vaccines and Antiviral Agents
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
Xiaoying Shen, Ryan Duffy, Robert Howington, Alethea Cope, Shanmugalakshmi Sadagopal, Haesun Park, Ranajit Pal, Suefen Kwa, Song Ding, Otto O. Yang, Genevieve G. Fouda, Roger Le Grand, Diane Bolton, Mariano Esteban, Sanjay Phogat, Mario Roederer, Rama R. Amara, Louis J. Picker, Robert A. Seder, M. Juliana McElrath, Susan Barnett, Sallie R. Permar, Robin Shattock, Anthony L. DeVico, Barbara K. Felber, George N. Pavlakis, Giuseppe Pantaleo, Bette T. Korber, David C. Montefiori, Georgia D. Tomaras
F. Kirchhoff, Editor
Xiaoying Shen
aDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
bDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Ryan Duffy
aDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
bDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Robert Howington
aDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
bDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Alethea Cope
fMucosal Infection & Immunity Group, Section of Infectious Diseases, Imperial College London, London, United Kingdom
Shanmugalakshmi Sadagopal
gDepartment of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA
Haesun Park
hVaccine & Gene Therapy Institute (VGTI), Oregon Health & Science University, Portland, Oregon, USA
Ranajit Pal
iAdvanced Bioscience Laboratories Inc., Rockville, Maryland, USA
Suefen Kwa
gDepartment of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA
Song Ding
jLaboratory of AIDS Immunopathogenesis, Service of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Otto O. Yang
kDepartment of Medicine, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
lDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California, USA
mAIDS Healthcare Foundation, Los Angeles, California, USA
Genevieve G. Fouda
aDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
Roger Le Grand
nCEA, Division of Immuno-Virology—IMDIT Center, DSV, iMETI, Fontenay-aux-Roses, Inserm-U1184, Université Paris-Sud, Orsay, France
Diane Bolton
oVaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA
Mariano Esteban
pDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
Sanjay Phogat
qSanofi Pasteur, Swiftwater, PA, USA
Mario Roederer
oVaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA
Rama R. Amara
gDepartment of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA
Louis J. Picker
hVaccine & Gene Therapy Institute (VGTI), Oregon Health & Science University, Portland, Oregon, USA
Robert A. Seder
oVaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA
M. Juliana McElrath
rVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Susan Barnett
sNovartis Vaccines and Diagnostics, Inc., Cambridge, Massachusetts, USA
Sallie R. Permar
aDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
cDepartment of Immunology, Duke University Medical Center, Durham, North Carolina, USA
dDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA
Robin Shattock
fMucosal Infection & Immunity Group, Section of Infectious Diseases, Imperial College London, London, United Kingdom
Anthony L. DeVico
tInstitute for Human Virology, Baltimore, Maryland, USA
Barbara K. Felber
uHuman Retrovirus Pathogenesis Section, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
George N. Pavlakis
vHuman Retrovirus Section, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
Giuseppe Pantaleo
jLaboratory of AIDS Immunopathogenesis, Service of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Bette T. Korber
wTheoretical Biology and Biophysics, Los Alamos National Laboratory, Los Álamos, New Mexico, USA
David C. Montefiori
bDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Georgia D. Tomaras
aDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
cDepartment of Immunology, Duke University Medical Center, Durham, North Carolina, USA
dDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA
eDepartment of Surgery, Duke University Medical Center, Durham, North Carolina, USA
F. Kirchhoff
Roles: Editor
DOI: 10.1128/JVI.03635-14

ABSTRACT
To evaluate antibody specificities induced by simian immunodeficiency virus (SIV) versus human immunodeficiency virus type 1 (HIV-1) envelope antigens in nonhuman primate (NHP), we profiled binding antibody responses to linear epitopes in NHP studies with HIV-1 or SIV immunogens. We found that, overall, HIV-1 Env IgG responses were dominated by V3, with the notable exception of the responses to the vaccine strain A244 Env that were dominated by V2, whereas the anti-SIVmac239 Env responses were dominated by V2 regardless of the vaccine regimen.
- Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
Xiaoying Shen, Ryan Duffy, Robert Howington, Alethea Cope, Shanmugalakshmi Sadagopal, Haesun Park, Ranajit Pal, Suefen Kwa, Song Ding, Otto O. Yang, Genevieve G. Fouda, Roger Le Grand, Diane Bolton, Mariano Esteban, Sanjay Phogat, Mario Roederer, Rama R. Amara, Louis J. Picker, Robert A. Seder, M. Juliana McElrath, Susan Barnett, Sallie R. Permar, Robin Shattock, Anthony L. DeVico, Barbara K. Felber, George N. Pavlakis, Giuseppe Pantaleo, Bette T. Korber, David C. Montefiori, Georgia D. Tomaras
Journal of Virology Jul 2015, 89 (16) 8643-8650; DOI: 10.1128/JVI.03635-14
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
Xiaoying Shen, Ryan Duffy, Robert Howington, Alethea Cope, Shanmugalakshmi Sadagopal, Haesun Park, Ranajit Pal, Suefen Kwa, Song Ding, Otto O. Yang, Genevieve G. Fouda, Roger Le Grand, Diane Bolton, Mariano Esteban, Sanjay Phogat, Mario Roederer, Rama R. Amara, Louis J. Picker, Robert A. Seder, M. Juliana McElrath, Susan Barnett, Sallie R. Permar, Robin Shattock, Anthony L. DeVico, Barbara K. Felber, George N. Pavlakis, Giuseppe Pantaleo, Bette T. Korber, David C. Montefiori, Georgia D. Tomaras
Journal of Virology Jul 2015, 89 (16) 8643-8650; DOI: 10.1128/JVI.03635-14